SEC Filings

10-K
AUDENTES THERAPEUTICS, INC. filed this Form 10-K on 03/13/2017
Entire Document
 

Table of Contents

 

 

 

 

Incorporated by reference

 

 

Exhibit
Number

 

Description of Document

 

Form

 

File
No.

 

Exhibit

 

Filing Date

 

Filed
Herewith

10.16†

 

Collaborative Development Agreement, dated January 24, 2014, by and between the Registrant and Genethon, a French not-for-profit organization.

 

S-1

 

333-208842

 

10.12

 

January 4, 2016

 

 

10.17†

 

License Agreement, dated September 26, 2014, by and between Cardiogen Sciences, Inc. and Fondazione Salvatore Maugeri.

 

S-1

 

333-208842

 

10.13

 

January 4, 2016

 

 

10.18†

 

Exclusive License Agreement with Know-How, dated July 28, 2015, by and between the Registrant and the University of Florida Research Foundation, Incorporated.

 

S-1

 

333-208842

 

10.14

 

January 4, 2016

 

 

10.19†

 

License Agreement, dated July 9, 2013, by and between the Registrant and ReGenX Biosciences, LLC.

 

S-1

 

333-208842

 

10.15

 

January 4, 2016

 

 

10.20†

 

License Agreement, dated November 3, 2015, by and between the Registrant and REGENXBIO Inc. (relating to CPVT).

 

S-1

 

333-208842

 

10.16

 

January 4, 2016

 

 

10.21†

 

License Agreement, dated November 3, 2015, by and between the Registrant and REGENXBIO Inc. (relating to Crigler-Najjar).

 

S-1

 

333-208842

 

10.17

 

January 4, 2016

 

 

10.22†

 

Exclusive License and Collaboration Agreement, dated May 3, 2016, by and between the Registrant and The Trustees of the University of Pennsylvania.

 

S-1

 

333-208842

 

10.18

 

June 16, 2016

 

 

10.23

 

First Amendment to License Agreement No. A13169, dated June 14, 2016, between the Registrant and the University of Florida Research Foundation, Inc.

 

S-1

 

333-208842

 

10.19

 

June 16, 2016

 

 

10.24††

 

First Amendment to Exclusive License and Collaboration Agreement, dated December 21, 2016, by and between the Registrant and The Trustees of the University of Pennsylvania.

 

 

 

 

 

 

 

 

 

X

10.25

 

Loan and Security Agreement, dated March 7, 2017, by and between the Registrant, each of its Qualified Subsidiaries, the several banks and other financial institutions party thereto, and Hercules Capital, Inc.

 

 

 

 

 

 

 

 

 

X

21.1

 

Subsidiary of the Registrant.

 

S-1

 

333-208842

 

21.1

 

January 4, 2016

 

 

23.1

 

Consent of KPMG LLP, Independent Registered Public Accounting Firm.

 

 

 

 

 

 

 

 

 

X

24.1

 

Power of Attorney. (See signature page hereto.)

 

 

 

 

 

 

 

 

 

X

31.1

 

Certification of Principal Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

X

31.2

 

Certification of Principal Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

X

F-33